Trials / Terminated
TerminatedNCT01693120
Evaluation of the Phased Radio Frequency Ablation System
Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 199 (actual)
- Sponsor
- Medtronic Cardiac Ablation Solutions · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation (AF) undergoing ablation with the Phased RF System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medtronic Phased RF Ablation System | Phased RF ablation |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2017-02-07
- Completion
- 2017-02-07
- First posted
- 2012-09-26
- Last updated
- 2025-02-13
- Results posted
- 2018-03-22
Locations
40 sites across 5 countries: United States, Canada, Hungary, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT01693120. Inclusion in this directory is not an endorsement.